Based on the animal model of MS, antagonists of the P2X7 receptor prevent demyelination and attenuate the functional decline resulting from the progression of the disease and most probably relieve the EAE symptoms [62]. The gene discussed is P2RX7; the disease is myeloid sarcoma.